We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of accounting rules by the country’s financial regulator.